Answer
Yes. It reduces the risk of serious RSV disease but cannot guarantee that infection or hospitalisation will not occur.
Sources for this answer
- Synagis 50 mg/0.5 ml solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.